200 related articles for article (PubMed ID: 21925772)
1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
de la Torre-Cisneros J; Fariñas MC; Castón JJ; Aguado JM; Cantisán S; Carratalá J; Cervera C; Cisneros JM; Cordero E; Crespo-Leiro MG; Fortún J; Frauca E; Gavaldá J; Gil-Vernet S; Gurguí M; Len O; Lumbreras C; Marcos MÁ; Martín-Dávila P; Monforte V; Montejo M; Moreno A; Muñoz P; Navarro D; Pahissa A; Pérez JL; Rodriguez-Bernot A; Rumbao J; San Juan R; Santos F; Varo E; Zurbano F;
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):735-58. PubMed ID: 21925772
[TBL] [Abstract][Full Text] [Related]
2. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.
Torre-Cisneros J; Aguado JM; Caston JJ; Almenar L; Alonso A; Cantisán S; Carratalá J; Cervera C; Cordero E; Fariñas MC; Fernández-Ruiz M; Fortún J; Frauca E; Gavaldá J; Hernández D; Herrero I; Len O; Lopez-Medrano F; Manito N; Marcos MA; Martín-Dávila P; Monforte V; Montejo M; Moreno A; Muñoz P; Navarro D; Pérez-Romero P; Rodriguez-Bernot A; Rumbao J; San Juan R; Vaquero JM; Vidal E; ; ;
Transplant Rev (Orlando); 2016 Jul; 30(3):119-43. PubMed ID: 27132815
[TBL] [Abstract][Full Text] [Related]
3. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A;
Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515
[TBL] [Abstract][Full Text] [Related]
4. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
5. [Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients].
Torre-Cisneros J; Fortún J; Aguado JM; de la Cámara R; Cisneros JM; Gavaldá J; Gurguí M; Lumbreras C; Martín C; Martín-Dávila P; Montejo M; Moreno A; Muñoz P; Pahissa A; Pérez JL; Rovira M; Bernardos A; Gil-Vernet S; Quijano Y; Rábago G; Román A; Varó E
Enferm Infecc Microbiol Clin; 2005; 23(7):424-37. PubMed ID: 16159543
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of cytomegalovirus disease in lung transplantation].
Gavaldà J; Monforte V; Len Ó
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():46-51. PubMed ID: 22541923
[TBL] [Abstract][Full Text] [Related]
7. Management of CMV infection and disease in transplant patients. 27-29 February 2004.
Razonable RR; Emery VC;
Herpes; 2004 Dec; 11(3):77-86. PubMed ID: 15960905
[TBL] [Abstract][Full Text] [Related]
8. Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
López-Medrano F; Cordero E; Gavaldá J; Cruzado JM; Marcos MÁ; Pérez-Romero P; Sabé N; Gómez-Bravo MÁ; Delgado JF; Cabral E; Carratalá J;
Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):526.e1-526.e20. PubMed ID: 23528341
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD
Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
[TBL] [Abstract][Full Text] [Related]
10. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
12. Strategies for managing cytomegalovirus in transplant recipients.
Razonable RR
Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
14. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
15. Management of cytomegalovirus infection in solid organ transplantation.
Kotton CN
Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
[TBL] [Abstract][Full Text] [Related]
16. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
Limaye AP
Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.
Martin JM; Danziger-Isakov LA
Pediatr Transplant; 2011 May; 15(3):229-36. PubMed ID: 21199215
[TBL] [Abstract][Full Text] [Related]
18. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
Bone Marrow Transplant; 1993 Oct; 12(4):399-403. PubMed ID: 8275040
[TBL] [Abstract][Full Text] [Related]
19. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
20. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
